Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Related Posts
Wall Street Giant JPMorgan Sees Clarity Act Driving Second-Half Upside
The crypto industry has spent years asking Washington for clear rules. It may be getting closer to an answer. JPMorgan…
XRP To $12: Analyst Reveals What Could Trigger The Breakout
The latest webcast from the market commentator known as Crypto Insight UK centres on a single contention: the technical and…
Bitcoin Price Steadies—Is a Meaningful Bounce on the Horizon?
Bitcoin price started a recovery wave above the $80,500 zone. BTC is now rising and might aim for a move…